MEMSCAP – Q1 2024

Double-Digit Growth in Aerospace and Medical Sales

Regulatory News:

MEMSCAP (Euronext Paris: MEMS), leading provider of high-accuracy, high-stability pressure sensor solutions for the aerospace and medical markets using MEMS technology (Micro Electro Mechanical Systems), today announced its earnings for the first quarter of 2024 ending March 31, 2024.

Analysis of consolidated revenue

Consolidated revenue from continuing operations (non-audited) for the first quarter of 2024 was EUR 3,832 thousand compared to EUR 3,668 thousand for the first quarter of 2023, thus a growth of 4.5%.

The distribution of consolidated revenue from continuing operations (non-audited) by market segment for the first quarter of 2024 is as follows:

Market segments / Revenue (In thousands of euros) – Non-audited	Q1 2023 (3 months)	Q1 2023 (%)	Q1 2024 (3 months)	Q1 2024 (%)
Aerospace	2,389	65%	2,536	66%
Medical	681	19%	929	24%
Optical communications	558	15%	341	9%
Others (Royalties from licensed trademarks)	40	1%	27	1%
Total revenue from continuing operations	3,668	100%	3,832	100%
(Any apparent discrepancies in totals are due to rounding.)

As in previous quarters, sales from the aerospace and medical segments, the Group's growth and profitability drivers, continued to grow by 12.8% and maintained their development momentum.

With a 6.1% growth this quarter, sales in the aerospace segment, the Group's largest market, reached a record quarterly high of EUR 2,536 thousand. Sales in the medical segment increased by 36.4% to EUR 929 thousand.